Oscar Health (NYSE:OSCR) Hits New 12-Month Low – Here’s What Happened

Oscar Health, Inc. (NYSE:OSCRGet Free Report)’s share price hit a new 52-week low during trading on Wednesday . The company traded as low as $11.58 and last traded at $11.72, with a volume of 6323054 shares changing hands. The stock had previously closed at $12.54.

Analyst Ratings Changes

A number of analysts have issued reports on the stock. Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and cut their price target for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Jefferies Financial Group began coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Oscar Health has an average rating of “Hold” and a consensus price target of $20.21.

Read Our Latest Analysis on OSCR

Oscar Health Price Performance

The stock’s 50 day moving average is $14.33 and its two-hundred day moving average is $15.57. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market capitalization of $2.94 billion, a PE ratio of -585.46 and a beta of 1.75.

Oscar Health (NYSE:OSCRGet Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, sell-side analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. GAMMA Investing LLC boosted its holdings in Oscar Health by 2,156.4% in the first quarter. GAMMA Investing LLC now owns 6,476 shares of the company’s stock valued at $85,000 after purchasing an additional 6,189 shares in the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of Oscar Health by 171.4% in the 4th quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company’s stock valued at $89,000 after buying an additional 4,185 shares in the last quarter. KBC Group NV grew its position in shares of Oscar Health by 56.1% in the 4th quarter. KBC Group NV now owns 7,107 shares of the company’s stock valued at $96,000 after buying an additional 2,555 shares during the last quarter. ORG Wealth Partners LLC acquired a new stake in Oscar Health during the 4th quarter worth $100,000. Finally, Alberta Investment Management Corp purchased a new stake in Oscar Health in the fourth quarter valued at $138,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Read More

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.